• MSR111 Assessing the Accuracy of Artificial Intelligence in Conducting Systematic Literature Reviews

    Jul 1, 2025, 00:00

  • HTA85 Developing a Value Assessment Framework for Modified New Drugs In China

    Jul 1, 2025, 00:00

  • MSR134 A Web-Based Application To Automate the Development of State-Transition Models in Oncology Using Published Survival Curves and Bayesian Calibration

    Jul 1, 2025, 00:00

  • PCR182 Real-World Hereditary Angioedema Attack Rates Before and After Berotralstat Initiation Among Patients With C1 Inhibitor Deficiency (Type I/II) and =8 Attacks Per Month

    Jul 1, 2025, 00:00

  • PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

    Jul 1, 2025, 00:00

  • EPH151 Depression Literacy in the Middle East and North Africa: A Scoping Review

    Jul 1, 2025, 00:00

  • RWD59 Uptake of national guidance for prescribing of SGLT-2 inhibitors for type 2 diabetes in the UK

    Jul 1, 2025, 00:00

  • EE450 National and State Population-Level Estimated Economic Impact of Ocrelizumab on Cumulative Disabilities Avoided and Work Productivity Under Different Access Scenarios in the United States

    Jul 1, 2025, 00:00

  • MSR85 Navigating Scarcity: Leveraging AI to Address the Challenges of Identifying Rare Disease Key Opinion Leaders

    Jul 1, 2025, 00:00

  • EE493 Cost Effectiveness of Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients in China

    Jul 1, 2025, 00:00

  • MSR59 An Open-Source R-Shiny Application Designed to Perform Frequentist and Bayesian Mixed Model Repeated Measures (MMRM)

    Jul 1, 2025, 00:00

  • HSD89 Unmet Need in Non-Metastatic Oral Cavity Cancer in the United States: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • EPH168 Determination of Medication Regimen Complexity Trends in Older Adult Patients With Insomnia: A Triangulation of Findings From Artificial Neural Network and Logistic Regression Analyses

    Jul 1, 2025, 00:00

  • P60 Feasibility of Replicating a Published Health Economic Model From an ICER Report Using Generative AI

    Jul 1, 2025, 00:00

  • RWD159 Burden of Illness in US Patients With Liver Cancer and Kidney Disease: A Real-World Claims Analysis

    Jul 1, 2025, 00:00

  • EE295 Modeling the Potential Health Benefits of Improving Nutrition in Australian Indigenous Populations

    Jul 1, 2025, 00:00

  • PCR16 Integrating Patient-Reported Outcomes in Clinical Care: Opportunities and Roadblocks from the Clinician Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • RWD145 Use of the Glucocorticoid Toxicity Index-Metabolic Domains Instrument to Quantify Glucocorticoid Toxicity in Adults With Chronic Inflammatory Demyelinating Polyneuropathy Using Electronic Health Records in the United States

    Jul 1, 2025, 00:00

  • EE315 Real-World Disease Management Costs for U.S. Patients With Muscle Invasive Bladder Cancer (MIBC) Following Radical Cystectomy (RC) in Contemporary Practice

    Jul 1, 2025, 00:00

  • MT11 How Does it Stack Up? User Comparison of the Ambu aScope 5 Uretero Against Reusable Ureteroscope Platforms

    Jul 1, 2025, 00:00

  • CO61 Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis

    Jul 1, 2025, 00:00

  • RWD124 Healthcare Resource Utilization for Medicare Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB) and Exacerbations Coinfected with Pseudomonas aeruginosa

    Jul 1, 2025, 00:00

  • MSR37 Improve Analyst Accuracy in Systematic Literature Reviews Using Reliant Tabular and LLM-Based Relevance Scoring

    Jul 1, 2025, 00:00

  • MT9 Assessment of Artificial Intelligence-Enabled Health Technologies: Our Initial Experience at Canada's Drug Agency

    Jul 1, 2025, 00:00

  • PCR200 Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • EE411 Estimating the Potential Cost-Effectiveness of Long-Acting Naltrexone versus Oral Naltrexone for Alcohol Use Disorder

    Jul 1, 2025, 00:00

  • MT33 A Systematic Literature Review and Meta-Analysis of Clinical Outcomes Across Five Malignant Procedures for Robotic-Assisted Surgery with the Da Vinci Single Port Surgical System

    Jul 1, 2025, 00:00

  • MSR15 Leveraging AI/Technology in Survey Design, Deployment, and Analysis

    Jul 1, 2025, 00:00

  • HPR6 Market Access Challenges for Innovative Medications in Women's Health in Canada: Overview of the Past 20 Years

    Jul 1, 2025, 00:00

  • PT12 Large-Language Models to Complement and Augment Literature Review: Hi! How Can I Help You?

    Jul 1, 2025, 00:00

  • EE257 Cost-Effectiveness of Sotagliflozin for Patients With Type 1 Diabetes and Chronic Kidney Disease, With and Without Dynamic Pricing

    Jul 1, 2025, 00:00

  • RWD107 Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing

    Jul 1, 2025, 00:00

  • HTA27 How Have Canada's Drug Agency Guidelines Impacted Choice of Model Structure and Use of Partitioned Survival Models in Oncology Submissions?

    Jul 1, 2025, 00:00

  • Table of Contents

    Jul 1, 2025, 00:00

  • HTA72 Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making

    Jul 1, 2025, 00:00

  • P54 Impact of Medicaid Enrollment Provisions on Postpartum Coverage and Resource Use in Three US States

    Jul 1, 2025, 00:00

  • PCR18 Comparative Analysis of Smartphone Application and Web-based Electronic Clinical Outcome Assessment (eCOA) Modalities

    Jul 1, 2025, 00:00

  • EE478 Healthcare Resource Utilization Among Fabry Disease Patients in the U.S.: Insightes From a Real-World Retrospective Study

    Jul 1, 2025, 00:00

  • HPR121 What Drug Characteristics Explain the Wide range of Manufacturer Rebates?

    Jul 1, 2025, 00:00

  • HPR97 The Social Distribution of Quality Adjusted Life Expectancy (QALE) Among Deprivation Subgroups in China

    Jul 1, 2025, 00:00

  • EE526 Impact of Recurrence Modelling on Cost-Effectiveness of New Treatments for Early Cancers

    Jul 1, 2025, 00:00

  • RWD137 Real-World Treatment Patterns of First-Line (1L) Ibrutinib in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL): Insights into Therapy Interruptions, Discontinuation and Next Treatment

    Jul 1, 2025, 00:00

  • HTA98 Mapping of Health Technology Assessment in China: Progress and Challenges from a Nationwide Repeated Cross-Sectional Survey

    Jul 1, 2025, 00:00

  • MT8 Can Robotics Narrow the Access Disparities in Minimally Invasive Surgery?

    Jul 1, 2025, 00:00

  • EE263 Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model

    Jul 1, 2025, 00:00

  • HPR119 Geographical and Temporal Variations in Availability of National Price Negotiated Novel Anticancer Drugs: A Spatial Statistical Study Based on Two Cross-Sectional Datasets in China

    Jul 1, 2025, 00:00

  • MT19 Exploring Patient Perceptions on an eHealth Application and Health Management Module in Hong Kong: A Qualitative Investigation

    Jul 1, 2025, 00:00

  • EE310 Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States

    Jul 1, 2025, 00:00

  • PCR109 Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance

    Jul 1, 2025, 00:00

  • EE303 The Time Value of Money driven by Early Disease-Modifying Interventions in Degenerative Disease

    Jul 1, 2025, 00:00

  • Author Reply

    Jul 1, 2025, 00:00

  • RWD164 ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access

    Jul 1, 2025, 00:00

  • EE287 Cost Effectiveness of Pembrolizumab in Combination with Chemotherapy for the Treatment of Patients with Locally Advanced or Metastatic HER2-Negative Gastric or Gastroesophageal Cancer in Mexico

    Jul 1, 2025, 00:00

  • RWD95 Healthcare Cost and Resource Utilization among First Line (1L) Treated Patients with Metastatic Non-small Cell Lung Cancer (mNSCLC): Analysis of SEER-Medicare Linked Claims in the US

    Jul 1, 2025, 00:00

  • RWD15 Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance

    Jul 1, 2025, 00:00

  • HPR143 Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain

    Jul 1, 2025, 00:00

  • HSD78 Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment

    Jul 1, 2025, 00:00

  • RWD117 Concordance of ER and HER2 Status by Claims-Based Algorithm and Large Language Models (LLM) Abstracted Clinical Notes in Patients With Metastatic Breast Cancer (mBC)

    Jul 1, 2025, 00:00

  • EE480 Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay

    Jul 1, 2025, 00:00

  • PCR248 Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)

    Jul 1, 2025, 00:00

  • MSR102 Validation Evidence of Self-Reported Measures for Healthcare Resource Utilization in Adult Populations: A Systematic Review

    Jul 1, 2025, 00:00

  • EE442 Assessing the Relationship Between Pruritus and Work Productivity Among Individuals With PBC and Pruritus: Results From the ITCH-E Study

    Jul 1, 2025, 00:00

  • RWD123 Pharmacovigilance Studies Using a Representative Sample From the French National Health Insurance Database (ESND): A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR201 Comparison of Rare Disease Patient and Caregiver Disease Burden in Terms of Economic, Social, and Interpersonal Impact and Impact on Quality Of Life: Results From an International Survey

    Jul 1, 2025, 00:00

  • HSD12 Predictors of Therapeutic Duplication Among Older Adults in the National Social Health in Aging Project

    Jul 1, 2025, 00:00

  • RWD98 Association of Combined Opioid and Marijuana Use with Major Depressive Disorder among Adults with Chronic Conditions in the United States (US)

    Jul 1, 2025, 00:00

  • RWD102 Impact of Adverse Event Definitions on Real-World Detection of Oncology Immune-Related Adverse Events

    Jul 1, 2025, 00:00

  • PCR239 Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing

    Jul 1, 2025, 00:00

  • PCR243 Developing a Checklist for Patient Engagement in Rare Disease Value Research

    Jul 1, 2025, 00:00

  • EE470 Cost-Effectiveness of Gabapentin, Pregabalin, and Duloxetine in the Treatment of Painful Diabetic Neuropathy: A Real-World Data-Based Net Benefit Regression Analysis

    Jul 1, 2025, 00:00

  • EE499 Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022

    Jul 1, 2025, 00:00

  • RWD71 Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States

    Jul 1, 2025, 00:00

  • HPR14 A Different Approach to the Overall Survival Conversation: A Bayesian Analysis of Overall Survival Benefits Among Oncology Accelerated Approvals

    Jul 1, 2025, 00:00

  • PCR124 Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US

    Jul 1, 2025, 00:00

  • PCR5 Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated With Neurofibromatosis Type 1 and Plexiform Neurofibroma: A Multinational, Qualitative Study

    Jul 1, 2025, 00:00

  • P33 Introduction of Distress Thermometer (DT) Screening in the US Community Oncology Setting: A Retrospective Study of Electronic Health Records (EHR) Integration

    Jul 1, 2025, 00:00

  • PCR214 Correlation and Predictors of EORTC QLQ-C30 GHS-QoL and EQ-5D VAS in Patients With Advanced NSCLC

    Jul 1, 2025, 00:00

  • The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care

    Jul 1, 2025, 00:00

  • RWD66 Utilizing Generative AI to Automate Model Selection and Network Meta-Analyses

    Jul 1, 2025, 00:00

  • PCR36 Enhancing Methods to Explore Meaningful Change in Patient Interviews: A Case Study in Spinocerebellar Ataxia (SCA)

    Jul 1, 2025, 00:00

  • SA14 Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19

    Jul 1, 2025, 00:00

  • EPH147 Distribution, Inequalities and Associated Factors of Unmet Medical Needs Among Older Adults: Evidence From The National Health Service Survey

    Jul 1, 2025, 00:00

  • HPR28 Interventions To Overcome the Challenges for Identifying Substandard, Spurious, Falsely Labeled, Falsified and Counterfeit Drugs (SSFFC). A Systematic Review

    Jul 1, 2025, 00:00

  • P42 Transportability of Treatment Effect Measures for Binary Outcomes in Population-Adjusted Indirect Comparisons

    Jul 1, 2025, 00:00

  • RWD90 Analysis and Management of Computable Operational Definition (CODef) Concept Variation Based on a Large Real-World Studies Library

    Jul 1, 2025, 00:00

  • MSR7 Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR

    Jul 1, 2025, 00:00

  • EE225 Cost Effectiveness Analysis of a Pharmacist-Led Clinical Decision Support System Powered by Machine Learning to Reduce Drug-Associated Acute Kidney Injury in the Adult Non-ICU Setting

    Jul 1, 2025, 00:00

  • HSD57 Highly Effective Use of a Medical Affairs Team with Medical Science Liaison-delivered Education: The SMART-MSL Study

    Jul 1, 2025, 00:00

  • HTA68 Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access

    Jul 1, 2025, 00:00

  • PCR15 Psychosocial Distress and Quality of Life Among Minority Men Diagnosed with Prostate Cancer: A Systematic Review

    Jul 1, 2025, 00:00

  • PCR88 Patient Attitudes and Emotions Predict Health Outcomes: Evidence From the National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • PCR108 Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management

    Jul 1, 2025, 00:00

  • PT2 Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study

    Jul 1, 2025, 00:00

  • HTA36 Horizon Scanning for Paroxysmal Nocturnal Hemoglobinuria in Brazil: Insights on Past Trends and Future Prospects

    Jul 1, 2025, 00:00

  • RWD29 A Retrospective Cohort Study Evaluating the Association Between Fibrosis-4 Index and Major Adverse Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatohepatitis

    Jul 1, 2025, 00:00

  • EE347 Updated 1-Year Fracture Incidence and Costs of Fragility Fractures in US Post-Fracture Patients Based on Commercial Claims Databases

    Jul 1, 2025, 00:00

  • EE292 Evaluating the Value of Over-the-Counter Oseltamivir for Influenza: A Cost-Utility Analysis From U.S. Payer and Societal Perspectives

    Jul 1, 2025, 00:00

  • MSR117 Estimation of Utilities for Patients with Metastatic Breast Cancer Using Vignette in Japan

    Jul 1, 2025, 00:00

  • HPR22 Comparing Hospital Prices Paid by Commercial Insurance Plans at 340B vs. Non-340B Hospitals: Implications for Employers and Patients

    Jul 1, 2025, 00:00

  • MSR62 Keeping With the Times: Emerging Methods for More Precise Survival Estimates to Inform Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • CO7 Progression From Systemic Lupus Erythematosus to Lupus Nephritis: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EPH110 Trends in Vaccinations by Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • PCR54 Preferences for Rapid Access Addiction Medicine Clinics Among Individuals with Problematic Alcohol Use A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • MT6 Improving Cancer Recurrence Detection using ctDNA Measures in Colorectal, Breast, and Non-small Cell Lung Cancers

    Jul 1, 2025, 00:00

  • EE409 A Systematic Literature Review of Health Economic Models Structures for Chronic Rhinosinusitis with Nasal Polyps

    Jul 1, 2025, 00:00

  • MSR118 Cognitive Impairment Detection through Recurrent Neural Networks and Mobile Health Technologies

    Jul 1, 2025, 00:00

  • RWD154 Healthcare Resource Utilization (HCRU) and Costs of Poly(ADP-ribose) Polymerase Inhibitors (PARPi) as First-Line Maintenance (1LM) Treatment for Ovarian Cancer (OC)

    Jul 1, 2025, 00:00

  • EE515 Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis

    Jul 1, 2025, 00:00

  • HPR9 From Data to Actionable Insight: A Collaborative Monitoring E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception

    Jul 1, 2025, 00:00

  • HSD92 Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges

    Jul 1, 2025, 00:00

  • EPH40 Association between Exposure to GLP-1 Treatment and Pancreatitis Risk in Obesity Patients: A Retrospective Database Study

    Jul 1, 2025, 00:00

  • EE519 Economic Evaluation of Healthcare Point Solutions Versus Standard Care to Supplement Benefit Plans for Behavioral Health Adults Patients Using Real-World Synthetic Data: A Doubly Robust Causal Analysis

    Jul 1, 2025, 00:00

  • RWD37 Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data

    Jul 1, 2025, 00:00

  • MSR100 Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool

    Jul 1, 2025, 00:00

  • EPH32 Is there a GLP-1 Halo Effect? Potentially Better Overall Health Management Due to Starting GLP-1 for Weight Loss

    Jul 1, 2025, 00:00

  • EPH21 Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants

    Jul 1, 2025, 00:00

  • EE427 Real-World Long-Term Clinical and Economic Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome in the United States

    Jul 1, 2025, 00:00

  • EE227 Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • EE277 Real-World Telehealth Utilization and Healthcare Costs in Commercially Insured Women With Breast Cancer: A Claims-Based Study

    Jul 1, 2025, 00:00

  • EE416 Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer

    Jul 1, 2025, 00:00

  • PCR52 Early Patient-Reported Satisfaction in Patients Initiated on Perfluorohexyloctane for Dry Eye Disease

    Jul 1, 2025, 00:00

  • MSR29 Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts

    Jul 1, 2025, 00:00

  • HTA63 Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions

    Jul 1, 2025, 00:00

  • CO24 Systematic Literature Reviews (SLRs) Of Clinical Outcomes And Patient-Reported Outcomes Of Recommended Treatments For Patients With Platinum-Resistant Ovarian Cancer (PROC)

    Jul 1, 2025, 00:00

  • RWD127 The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims

    Jul 1, 2025, 00:00

  • RWD91 A Retrospective Analysis of Real-World Data: Assessing and Predicting Cardiovascular Risk Associated with Calcium Channel Blockers in Patients with Hypertension

    Jul 1, 2025, 00:00

  • HSD60 Impact of Pharmacist Managed Pulmonary Arterial Hypertension Program on TYVASO Adherence

    Jul 1, 2025, 00:00

  • PCR193 Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey

    Jul 1, 2025, 00:00

  • EPH5 Disability Progression and Associated Costs in Incident Early-Onset Myasthenia Gravis Patients in France A Longitudinal Cohort Study

    Jul 1, 2025, 00:00

  • PT1 Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example

    Jul 1, 2025, 00:00

  • HSD112 Trends in Attainment of the Kidney Health Evaluation for Patients With Diabetes Measure Among Insured Individuals in the US, 2021-2024

    Jul 1, 2025, 00:00

  • EE441 Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail

    Jul 1, 2025, 00:00

  • EE385 Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022

    Jul 1, 2025, 00:00

  • MSR112 Can Multi-Cancer Early Detection Tests Reduce Cancer Mortality?

    Jul 1, 2025, 00:00

  • PT17 Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR25 Artificial Intelligence Software as a Medical Devi Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe

    Jul 1, 2025, 00:00

  • HPR84 Trends in Respiratory Pathogen Testing With Individual Pathogen, Small Panel, or Large Panel Polymerase Chain Reaction (PCR) Tests Before and After the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE) Ended

    Jul 1, 2025, 00:00

  • PCR169 Impact of Primary Care Subsidies on Healthcare Utilization: Evidence From Singapore's Merdeka Generation Package

    Jul 1, 2025, 00:00

  • HTA84 Payer Perceptions on Creating a National Value assessment Body in the US

    Jul 1, 2025, 00:00

  • HPR140 The Importance of Medicare Advantage Plan Design and Impact on Health Equity

    Jul 1, 2025, 00:00

  • RWD35 Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncolo ...

    Jul 1, 2025, 00:00

  • EE504 Characterizing the Burden and Drivers of Healthcare Utilization and Spending for Epilepsy and Seizures in the U.S., 2016-2022

    Jul 1, 2025, 00:00

  • HTA19 The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland

    Jul 1, 2025, 00:00

  • RWD128 Device Longevity and Survival After Cardiac Resynchronization Therapy Pacemaker (CRT-P) Implantation in the Brazilian Public Health System (SUS): 12-Year Real-World Data Analysis

    Jul 1, 2025, 00:00

  • PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Jul 1, 2025, 00:00

  • P24 AI Tools for Literature Reviews: Are Current Guidelines Meeting the Needs of Researchers?

    Jul 1, 2025, 00:00

  • MSR80 Evaluation of Marginal Healthcare Expenditures and Health-related Quality of Life in Multiple Sclerosis with a Bayesian Quantile Machine Learning Approach

    Jul 1, 2025, 00:00

  • EE271 30-Day All-Cause Readmission Outcomes Among Kidney Transplant Recipients with vs. without Autosomal Dominant Polycystic Kidney Disease

    Jul 1, 2025, 00:00

  • EE513 Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab

    Jul 1, 2025, 00:00

  • PCR164 Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis

    Jul 1, 2025, 00:00

  • RWD156 Validation of Real-World Recurrence-Free Survival (rwRFS) and Distant Metastasis-Free Survival(rwDMFS) Endpoints in Early-Stage Melanoma

    Jul 1, 2025, 00:00

  • MT40 Prospective, Comparative Study Between Fully-Automated and Semi-Automated Whole Blood Processing Systems in a Colombian Blood Bank Center

    Jul 1, 2025, 00:00

  • EPH33 Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study

    Jul 1, 2025, 00:00

  • RWD134 Follow Me, If You Can: How Tokenized Linkage Extends Patient Observations in Real-World Databases - the Komodo Research Dataset Example

    Jul 1, 2025, 00:00

  • P35 Integrating Patient-Reported Outcomes in Clinical Care - Opportunities and Roadblocks From the Patient Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • CO21 Real-World Evidence on Clinical Outcomes and Safety of Trastuzumab Biosimilar in Colombian Breast Cancer Patients

    Jul 1, 2025, 00:00

  • PCR167 Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women

    Jul 1, 2025, 00:00

  • HSD50 Racial/Ethnic Disparities in Veterans' Healthcare Experiences Across VA and Non-VA Settings: An Analysis of the Medical Expenditure Panel Survey (2018-2019)

    Jul 1, 2025, 00:00

  • P30 Navigating Real-World Data (RWD) Complexities: Operational Assessment Strategy to Identify Fit-For-Purpose Data Sources for Real-World Evidence (RWE) Studies With Regulatory Purpose (OASIS)

    Jul 1, 2025, 00:00

  • CO54 Systematic Literature Review and Network Meta-Analysis of Crovalimab Compared With Eculizumab, Ravulizumab and Best Supportive Care in Paroxysmal Nocturnal Hemoglobinuria

    Jul 1, 2025, 00:00

  • RWD167 Inpatient Hospitalization Trends for COPD in 2018 versus 2021 in United States: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • HTA79 Annual Direct Medical Costs with Beta-Thalassemia in the Brazilian Public Healthcare System (SUS)

    Jul 1, 2025, 00:00

  • EE260 A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens

    Jul 1, 2025, 00:00

  • EE483 Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System

    Jul 1, 2025, 00:00

  • MSR93 DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis

    Jul 1, 2025, 00:00

  • HTA11 A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices

    Jul 1, 2025, 00:00

  • EPH64 Trends and Disparities in Weight Loss Activities Among Adults With Prediabetes and Obesity in the United States: 2009-2020

    Jul 1, 2025, 00:00

  • PT9 Application of ML-NMR to Time-to-Event Outcomes Using Parametric Models and Flexible Parametric (Spline) Models: A Case Study Using A Simulated Dataset

    Jul 1, 2025, 00:00

  • CO29 Medication Utilization Post Selective Laser Trabeculoplasty or Minimally Invasive Glaucoma Surgeries in Patients With Open-Angle Glaucoma or Ocular Hypertension: A Systematic Review of Recent Literature

    Jul 1, 2025, 00:00

  • MSR114 Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis

    Jul 1, 2025, 00:00

  • RWD78 Psychotropic Medication Treatment Patterns in Employee Dependents with Autism Spectrum Disorder

    Jul 1, 2025, 00:00

  • HSD29 National Assessment of Prostate and Colon Cancer Screening Using National Health Interview Survey (NHIS)

    Jul 1, 2025, 00:00

  • EPH51 Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study

    Jul 1, 2025, 00:00

  • HPR110 Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D

    Jul 1, 2025, 00:00

  • MSR119 Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)

    Jul 1, 2025, 00:00

  • EPH144 Disease and Economic Burden of Dengue in Colombia, 2018-2022

    Jul 1, 2025, 00:00

  • MSR121 An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening

    Jul 1, 2025, 00:00

  • HTA13 Analysis of Reimbursement Outcomes for Oncology Therapies in Quebec, Canada

    Jul 1, 2025, 00:00

  • MSR61 Psychometric Validation of the Sunlight Exposure Diary and Erythropoietic Protoporphyria Impact Questionnaire (EPIQ) Using Data from the AURORA Clinical Study in Erythropoietic Protoporphyria (EPP)

    Jul 1, 2025, 00:00

  • EPH36 Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021

    Jul 1, 2025, 00:00

  • HTA80 Consistency in Reimbursement Decisions for Pediatric Rare Disease Drugsat Canadian HTA Agencies: CDA Versus INESSS

    Jul 1, 2025, 00:00

  • MT16 Economic Impact of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants

    Jul 1, 2025, 00:00

  • EE335 Economic Burden of Hwabyeong in South Korea: An Analysis of Direct, Non-Medical, and Indirect Costs

    Jul 1, 2025, 00:00

  • HTA69 A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments

    Jul 1, 2025, 00:00

  • EE393 Cost-Effectiveness of Umeclidinium/Vilanterol Combination Therapy for Group B COPD Patients

    Jul 1, 2025, 00:00

  • HSD72 Virtual Cancer Screening and Support Program: A Model for Improving Cancer Care Continuity Through Screening, Diagnosis, Treatment, and Survivorship

    Jul 1, 2025, 00:00

  • PCR227 Mapping the NEI-VFQ-25 to the EQ-5D-Y-3L and CHU-9D among High School Students with Myopia in China

    Jul 1, 2025, 00:00

  • PCR127 A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?

    Jul 1, 2025, 00:00

  • EPH7 The Impact of Endoscopic Screening Programs for Gastric Cancer in Japan

    Jul 1, 2025, 00:00

  • HTA23 Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs

    Jul 1, 2025, 00:00

  • EE275 Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study

    Jul 1, 2025, 00:00

  • EE371 A European perspective on Health Resource Utilization (HRU) and Cost outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review

    Jul 1, 2025, 00:00

  • MT29 Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime

    Jul 1, 2025, 00:00

  • PCR180 Healthcare Burden Among Patients with Graves Disease: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • HPR26 Are Existing Descriptions of Unmet Medical Need Fit for Purpose in the CMS Drug Negotiation Program Context?

    Jul 1, 2025, 00:00

  • EPH108 Prenatal Exposure to Antiseizure Medication and Risk of Adverse Obstetrical Outcomes: A Population-Based Study

    Jul 1, 2025, 00:00

  • EE468 Cost-Effectiveness Analysis of Baricitinib Compared to Standard of Care in Improving Symptoms of Alopecia Areata for the Patients in the U.S. From the Healthcare Payer Perspective

    Jul 1, 2025, 00:00

  • RWD89 Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints

    Jul 1, 2025, 00:00

  • HTA70 A Review of NICE UK Submissions for Antibody-Drug Conjugates in Oncology

    Jul 1, 2025, 00:00

  • MSR36 Methods for Handling Non-Proportional Hazards in Economic Modeling

    Jul 1, 2025, 00:00

  • EPH183 Gender-Based Gaps In Access to Tricuspid Valve Interventions In England

    Jul 1, 2025, 00:00

  • PCR84 Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

    Jul 1, 2025, 00:00

  • EPH113 Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population

    Jul 1, 2025, 00:00

  • RWD153 A US Real-World Study of Weight Trajectory and Hypothalamic Damage Among Patients With Acquired Hypothalamic Obesity

    Jul 1, 2025, 00:00

  • MSR39 Large Language Model and Contextual Prioritization of Titles and Abstracts for Systematic Review Screening

    Jul 1, 2025, 00:00

  • HTA92 Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia

    Jul 1, 2025, 00:00

  • PCR34 More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives

    Jul 1, 2025, 00:00

  • HPR93 A Targeted Literature Review of Value-Based Agreements (VBAs) for Cell and Gene Therapies in the United States

    Jul 1, 2025, 00:00

  • PCR179 Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • HTA60 Impact of a Digital Musculoskeletal Program on Healthcare Spending Among Participants with Chronic Musculoskeletal Pain and Comorbidities

    Jul 1, 2025, 00:00

  • PCR190 Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)

    Jul 1, 2025, 00:00

  • PCR79 Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions

    Jul 1, 2025, 00:00

  • HTA1 Pathways to MBS Funding for In-Vitro Diagnostics: Timelines and Success Rates in Australia

    Jul 1, 2025, 00:00

  • HPR116 Characterizing Social Determinants of Health in the Population Receiving Pneumococcal Vaccine in a National Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • HPR127 Evolution of Technology Diffusion Within Brazilian Universal Healthcare System (Sistema Único De Saúde – SUS) 2+ Years After Listing of Antiangiogenics Treatment for Diabetic Macular Edema (DME)

    Jul 1, 2025, 00:00

  • HSD56 Bridging Racial Disparities in Aspirin Therapy for Preeclampsia Prevention Using Virtual Maternity Care

    Jul 1, 2025, 00:00

  • RWD48 Impact of Circulating Tumor DNA (ctDNA) Burden Among Patients with Head and Neck Dquamous Cell Carcinoma (HNSCC) - A RWE Analysis

    Jul 1, 2025, 00:00

  • HPR45 The Cost of 340B to States

    Jul 1, 2025, 00:00

  • PCR85 The Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives: Assessing the Content Validity of Dedicated Patient-Reported Outcomes Measurement (PROM) Instruments

    Jul 1, 2025, 00:00

  • EE355 Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada

    Jul 1, 2025, 00:00

  • EE290 Potential Impact of New Strategies of Infant Immunization in the Disease and Economic burden of RSV in Colombia

    Jul 1, 2025, 00:00

  • PCR60 Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis

    Jul 1, 2025, 00:00

  • HPR153 The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective

    Jul 1, 2025, 00:00

  • HPR158 Is the Biologics Price Competition and Innovation Act Working as Intended?

    Jul 1, 2025, 00:00

  • EE356 Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care

    Jul 1, 2025, 00:00

  • RWD130 Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • EE451 Assessing the Operational Efficiency of a Vial Filling Robot in an Outpatient or a Community Pharmacy

    Jul 1, 2025, 00:00

  • EE254 Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States

    Jul 1, 2025, 00:00

  • HPR146 Real-World BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) Testing Trends by Race for Patients with Metastatic Prostate Cancer (mPC) from 2015 to 2024 in the Community Oncology Setting in the United States (US)

    Jul 1, 2025, 00:00

  • PCR222 Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial

    Jul 1, 2025, 00:00

  • HPR125 Increasing Recognition Towards Inclusion of Patient Preferences in Healthcare Intervention Development and Access- Current Landscape and Way Forward

    Jul 1, 2025, 00:00

  • RWD100 Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data

    Jul 1, 2025, 00:00

  • MSR18 Machine Learning Prediction of 3-Year Mortality in Patients Undergoing Percutaneous Coronary Intervention for Coronary Artery Disease

    Jul 1, 2025, 00:00

  • HPR48 Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • EPH126 Identify the Adverse Drug Reactions Among Rheumatoid Arthritis Patients Being Administered Specific Classes of Disease-Modified Anti-Rheumatic Drugs (DMARDs)

    Jul 1, 2025, 00:00

  • EPH172 Exploring Pregnancy-Related Coding Practices in Administrative Claims Data: Insights for Health Outcomes Researchers

    Jul 1, 2025, 00:00

  • EE232 Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia

    Jul 1, 2025, 00:00

  • EPH99 Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)

    Jul 1, 2025, 00:00

  • RWD70 Barriers to Genetic Risk Factor Molecular Testing in CLL: An Analysis of Real-World Practice and Alignment with 2023 Guidelines in Germany

    Jul 1, 2025, 00:00

  • HPR5 Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022

    Jul 1, 2025, 00:00

  • PCR17 Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • MSR2 Developing a Feature Selection Workflow for Variable-Rich Data: A Case Study Utilizing Claims Data to Build Classifiers for the Prediction of Opioid Use Disorder Among Persons Authorized to Purchase Medical Cannabis

    Jul 1, 2025, 00:00

  • P53 Alignment Between CDA Recommendations and pCPA Negotiation Outcomes: Exploring Factors Influencing Reimbursement Success

    Jul 1, 2025, 00:00

  • EPH122 First-Trimester Antiepileptic Drug Exposure and Adverse Pregnancy Outcomes: Insights from a Cohort Study in the US

    Jul 1, 2025, 00:00

  • HPR89 What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?

    Jul 1, 2025, 00:00

  • EE476 Cost-Effectiveness of Pegfilgrastim Versus 5-day Filgrastim in Early Breast Cancer Patients Undergoing Neoadjuvant and Adjuvant Chemotherapy: A Trial-Based Economic Evaluation

    Jul 1, 2025, 00:00

  • EPH123 An Epidemiological Assessment of the Stroke Burden in Hungary Using Data From the Global Burden of Disease Study (1990–2021)

    Jul 1, 2025, 00:00

  • HPR138 2025 Review of Gene Therapy Access Landscape

    Jul 1, 2025, 00:00

  • CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmento 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)

    Jul 1, 2025, 00:00

  • RWD39 Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • EE430 Medicare Cost Comparison of Transcarotid Artery Revascularization (TCAR) Versus Transfemoral Carotid Artery Stenting (TF-CAS)

    Jul 1, 2025, 00:00

  • PCR73 Discontinuation of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis

    Jul 1, 2025, 00:00

  • PCR76 Do Existing Caregiver Assessments Measure What's Important to Caregivers?

    Jul 1, 2025, 00:00

  • MT3 Clinical and Economic Benefits of Branched Endovascular Stent Grafting for Intact Thoracoabdominal Aortic Aneurysm Repair: A Real-World Data Analysis

    Jul 1, 2025, 00:00

  • EPH158 National Assessment of Depression Between Early vs Late Adolescents Using National Survey of Child Health Survey

    Jul 1, 2025, 00:00

  • HTA55 Effectiveness of Cell-Free Tumor DNA Tests in Early Lung Cancer Detection

    Jul 1, 2025, 00:00

  • PCR224 Examination of Different Segments of Health Literacy and Health Awareness Among Pregnant Women

    Jul 1, 2025, 00:00

  • EE243 Cost of Hypertension Cardiovascular and Renal Complications in Private Healthcare System in Brazil

    Jul 1, 2025, 00:00

  • HSD98 Bariatric Surgery Costs in Chile: Cost of a Comprehensive, Evidence-Based, and High-Quality of Care Program

    Jul 1, 2025, 00:00

  • PCR47 Social Listening: A Content Analysis of Social Media Discussions in Prader Willi Syndrome (PWS)

    Jul 1, 2025, 00:00

  • EE246 Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperp ...

    Jul 1, 2025, 00:00

  • EE447 Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations

    Jul 1, 2025, 00:00

  • RWD1 Hemoglobin Levels and Social Determinants of Health as Risk-factors of End-Organ Damage in Sickle Cell Disease: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • EE237 Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data

    Jul 1, 2025, 00:00

  • RWD16 Leveraging CMS Medicare Data for Oncology RWE: Benefits, Limitations, and Opportunities, and Insights into Enrollment Patterns

    Jul 1, 2025, 00:00

  • PT18 Prescribing Trends of Disease-Modifying Medications in Texas Medicaid Enrollees with Sickle Cell Disease

    Jul 1, 2025, 00:00

  • PCR61 Exploring the Health and Well-being of Pediatric Caregivers within Chinese Cultural Contexts: A Systematic Review of Qualitative Studies from Chinese Databases

    Jul 1, 2025, 00:00

  • HSD67 Heterogeneity in Preferences for HIV Self-Testing Among Ugandan Men

    Jul 1, 2025, 00:00

  • EPH87 Influence of Overweight and Obesity on Disease Progression, Healthcare Utilization and Costs Among People With Prediabetes: A Cohort Study in China

    Jul 1, 2025, 00:00

  • RWD165 Pioneering the Integration of Health-Equity Variables Into an Administrative Claims Database: A Step Forward in the Journey to Supporting Underserved Populations

    Jul 1, 2025, 00:00

  • HTA42 Better Off Dead: Mitigating For Situations Where Improving Survival Isn't Cost-Effective

    Jul 1, 2025, 00:00

  • EE349 Costs of Type 1 Diabetes Acute and Chronic Complications in Brazil Private Healthcare System

    Jul 1, 2025, 00:00

  • EE365 Real-World Healthcare Resource Utilization and Economic Burden Associated With Progressive Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States

    Jul 1, 2025, 00:00

  • EPH135 Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023

    Jul 1, 2025, 00:00

  • PCR194 Qualitative Evaluation of a Tool for Collecting Stated and Revealed Patient Preferences in the Context of Atypical Antipsychotics for the Treatment of Depression or Bipolar Disorder in Adults

    Jul 1, 2025, 00:00

  • EE403 Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • EE360 Short-Term (180-Day) Health Care Costs for Patients With Commercial or Medicare Advantage (MA) Insurance Initiating Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy for Diabetes

    Jul 1, 2025, 00:00

  • PCR151 Relationship Between Patient Engagement and Weight Management in a Pharmacist-led Clinic within a Managed Care Organization

    Jul 1, 2025, 00:00

  • RWD172 Implementation of New Real-World Data Quality Frameworks and Initiatives to Address Challenges in Oncology Electronic Health Record (EHR)-Derived Databases for Research

    Jul 1, 2025, 00:00

  • EE320 Impact of Diagnosis Delay on Healthcare Resource Utilization (HCRU) among Patients with Pulmonary Arterial Hypertension (PAH)

    Jul 1, 2025, 00:00

  • CO14 Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • HPR56 Does the 340B Program Encourage and Reward Non-Profit Hospital Consolidation?

    Jul 1, 2025, 00:00

  • HPR70 Revisiting Conflicts in Population-Adjusted Indirect Comparisons: A Duality Perspective

    Jul 1, 2025, 00:00

  • EE364 Economic Evaluation of Single-Inhaler Extrafine Beclometasone Dipropionate/formoterol fumarate/glycopyrronium (Trimbow®) in Adult Patients with Uncontrolled Asthma in Mexico

    Jul 1, 2025, 00:00

  • EE500 Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China

    Jul 1, 2025, 00:00

  • PCR81 Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey

    Jul 1, 2025, 00:00

  • EE288 Economic Burden and Healthcare Resource Utilization (HCRU) Associated with High-Risk Papillary Stage Ta T1 (PAPTa1) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients, 2008-2019

    Jul 1, 2025, 00:00

  • HPR21 Association between Socioeconomic Factors and Guideline-Directed Medical Therapy (GDMT) Utilization Among Medicare Beneficiaries with Heart Failure with Reduced Ejection Fraction (HFrEF)

    Jul 1, 2025, 00:00

  • HSD53 The COM-IC Project: Recommendations for Core Outcome Measurement To Improve (Routine Dementia) Care Quality in Australian Aged Care Settings

    Jul 1, 2025, 00:00

  • HPR170 Private Insurance May Fail to Protect Against Healthcare Financial Hardship, Evidence from the 2018 and 2019 Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • RWD40 Real World Treatment Patterns for Castration-Sensitive Prostate Cancer Between 2012 and 2024 : A Systematic Review

    Jul 1, 2025, 00:00

  • HSD36 Self-reported CAHPS Quality Measures by Medicare Beneficiary Social Vulnerability Index

    Jul 1, 2025, 00:00

  • HPR105 Evaluation of the Cost of Treatment on Endometriosis in the Hungarian Public-Funded Healthcare System

    Jul 1, 2025, 00:00

  • EE528 Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Metastatic Gastric/Gastroesophageal Junction Cancer in Commercially Insured Patients in the United States

    Jul 1, 2025, 00:00

  • PCR184 Measuring and Reporting Health-Related Quality of Life (HRQoL) in Locally Advanced/Metastatic Urothelial Cancer (La/mUC) Research: Capturing Outcomes That Really Matter to Patients

    Jul 1, 2025, 00:00

  • EE421 Healthcare Cost Comparison Between 1L Ibrutinib and Acalabrutinib in Chronic Lymphocytic Leukemia Patients in the Veterans Affairs Population

    Jul 1, 2025, 00:00

  • EPH84 Epidemiological Insights in Cornelia-de-Lange Syndrome: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HPR134 Hepatitis C Elimination via Subscription-Based Payment Models: A Synthetic Control Study from Washington and Louisiana

    Jul 1, 2025, 00:00

  • HPR142 The Evolution of Value-Based Agreements in US Healthcare: Barriers, Opportunities, and Future Prospects

    Jul 1, 2025, 00:00

  • MSR53 Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy

    Jul 1, 2025, 00:00

  • SA13 An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study

    Jul 1, 2025, 00:00

  • PCR78 Approaches to Decreasing Emotional Burden during Qualitative Interviews to Improve Data Quality and Participant Engagement

    Jul 1, 2025, 00:00

  • RWD111 Unmet Need in CIDP Patients Treated With Immunoglobin: Results of a Multinational Real-World Survey

    Jul 1, 2025, 00:00

  • EE509 Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel

    Jul 1, 2025, 00:00

  • HSD100 Enhanced Outcomes and Reduced Healthcare Utilization with Specialized Home Healthcare Service Providers for Ostomy and Urological Patients: Comparative Research with Pharmacy-Based Care

    Jul 1, 2025, 00:00

  • EE297 Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil

    Jul 1, 2025, 00:00

  • MSR90 From Bias to Confiden Exploring Quantitative Bias Analysis’ (QBA’s) Role in Matching Adjusted Indirect Treatment Comparison

    Jul 1, 2025, 00:00

  • MSR124 Impact of NICE Severity Modifiers on Willingness-to-Pay Thresholds

    Jul 1, 2025, 00:00

  • EE209 Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective

    Jul 1, 2025, 00:00

  • EPH119 Chronic Conditions Significantly Increase Risk of Severe RSV Outcomes in Medicaid Beneficiaries Aged 18-59 Years: A Claims Data Analysis

    Jul 1, 2025, 00:00

  • P52 A Policy Framework for Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment (HTA)

    Jul 1, 2025, 00:00

  • EPH129 Evaluation of Availability, Prices, and Affordability of Medicines for Hepatitis B and Hepatitis C Viruses at Community Pharmacies in a Senatorial District in North-Central Nigeria

    Jul 1, 2025, 00:00

  • HSD24 Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • PCR64 Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability

    Jul 1, 2025, 00:00

  • CO37 A Clinical Prediction Model of Asymptomatic Left Ventricular Dysfunction in Survivors of Childhood Cancer in Ontario, Canada

    Jul 1, 2025, 00:00

  • EE467 Acute Myocardial Infarction and Associated Healthcare Resource Utilization and Costs Among U.S. Patients With Extreme High Versus Low Lipoprotein (a)

    Jul 1, 2025, 00:00

  • EPH75 Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection

    Jul 1, 2025, 00:00

  • RWD22 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer

    Jul 1, 2025, 00:00

  • CO11 Comparative Analysis of Robotic-Assisted, Laparoscopic, and Open Radical Nephrectomy: Trends, Costs, and Clinical Outcomes

    Jul 1, 2025, 00:00

  • MT18 Impact of Single-Patient Use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in Canada

    Jul 1, 2025, 00:00

  • EE420 Compare the Return on Investment of Pulsed Field Ablation With Conventional Thermal Ablation for Treatment of Atrial Fibrillation in China

    Jul 1, 2025, 00:00

  • PCR166 Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study

    Jul 1, 2025, 00:00

  • EE224 Evaluating Attributes of Non-Oncology Orphan Approvals From 2015-2024

    Jul 1, 2025, 00:00

  • EE319 Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States

    Jul 1, 2025, 00:00

  • MSR125 Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models

    Jul 1, 2025, 00:00

  • CO45 Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies

    Jul 1, 2025, 00:00

  • PCR94 Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)

    Jul 1, 2025, 00:00

  • EE265 Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial

    Jul 1, 2025, 00:00

  • EPH150 Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network

    Jul 1, 2025, 00:00

  • PT10 Patient-Reported Outcome Endpoint Emulation in Heart Failure External Control Arm Study (EMULATE-HF PRO-ECA Study)

    Jul 1, 2025, 00:00

  • PCR107 Differential Item Functioning With the National Eye Institute Visual Function Questionnaire-25 in Patients With Vitreomacular Traction

    Jul 1, 2025, 00:00

  • EPH10 Investigating the Pain Severity and Frequent Exercise Relationship in United States Adults Using the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • HSD19 Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach

    Jul 1, 2025, 00:00

  • EE405 Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results

    Jul 1, 2025, 00:00

  • EE236 A Health Economic Evaluation of an Artificial Intelligence-Assisted Prescription Review System in a Real-World Setting in China

    Jul 1, 2025, 00:00

  • MSR115 Prediction of Myasthenia Gravis (MG) Crisis Events by a Machine Learning (ML) Algorithm

    Jul 1, 2025, 00:00

  • EE294 Economic Burden of Avoidable Blindness Due to Diabetic Macular Edema in Ecuador

    Jul 1, 2025, 00:00

  • EE392 State of Evidence on Cost-Effectiveness Analysis of Health Technologies in Colombia: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • EE305 Cost-Effectiveness of Maribavir for Post-Transplant Refractory (With or Without Resistance) Cytomegalovirus Infection in China

    Jul 1, 2025, 00:00

  • PT13 Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?

    Jul 1, 2025, 00:00

  • EE410 Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada

    Jul 1, 2025, 00:00

  • CO91 Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database

    Jul 1, 2025, 00:00

  • EE354 Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study

    Jul 1, 2025, 00:00

  • EE517 Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec

    Jul 1, 2025, 00:00

  • PCR9 Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation

    Jul 1, 2025, 00:00

  • CO22 Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study

    Jul 1, 2025, 00:00

  • PCR137 Patient and Physician Perspectives on Attributes of IO-Containing? Perioperative Treatments in Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer (NSCLC)

    Jul 1, 2025, 00:00

  • CO18 Assessing the Comorbidity Burden of Ehlers-Danlos Syndromes (EDS): An Analysis Using US Real-World Data

    Jul 1, 2025, 00:00

  • PCR128 Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)

    Jul 1, 2025, 00:00

  • HPR36 Estimated Impact of the Inflation Reduction Act on Out-of-Pocket Spend Among Medicare Part D Beneficiaries with Cancer

    Jul 1, 2025, 00:00

  • EPH138 Dynamic Population Modelling Indicates a Flavored EVP Ban in the UK May Negatively Impact Population Health

    Jul 1, 2025, 00:00

  • EPH89 What Are the Characteristics Associated With Frequent Physical Exercise Among Adults With Arthritis? Results of a National Survey in the United States

    Jul 1, 2025, 00:00

  • CO34 Real-World Cancer Recurrence and Overall Survival Outcomes in Muscle-Invasive Bladder Cancer (MIBC) Patients Treated With Radical Cystectomy (RC): A Retrospective Surveillance, Epidemiology, and End Results-Medicare Study

    Jul 1, 2025, 00:00

  • EPH52 Protocol for a Real-World Retrospective Study on Chronic Obstructive Pulmonary Disease Outcomes Among Individuals Switching to Heated Tobacco Products Compared to Continued and Former Cigarette Smokers in Japan

    Jul 1, 2025, 00:00

  • PCR115 Qualitative Assessment of the Idiopathic Hypersomnia Severity Scale: Suitability for Use As a Clinical Trial Endpoint as Demonstrated in NCT05156047

    Jul 1, 2025, 00:00

  • EPH136 Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database

    Jul 1, 2025, 00:00

  • HPR64 ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US

    Jul 1, 2025, 00:00

  • EPH124 EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)

    Jul 1, 2025, 00:00

  • MSR75 Comparison of Generative AI and Manual Data Programming in a Lupus Health Productivity Loss Study

    Jul 1, 2025, 00:00

  • EE202 Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review

    Jul 1, 2025, 00:00

  • PCR31 The Impact of Mucopolysaccharidosis Type III (MPS III) on Family and Finances: A Caregiver Perspective

    Jul 1, 2025, 00:00

  • MSR10 Real-time Predictions of Maternity Episode Expenses Using Machine Learning

    Jul 1, 2025, 00:00

  • CO79 Estimating the Effect of a Discontinued Amyotrophic Lateral Sclerosis Treatment on Time-to-Death Using Sequential Target Trial Emulation

    Jul 1, 2025, 00:00

  • PCR129 Utility Values From Individuals With Knee Osteoarthritis in the UK

    Jul 1, 2025, 00:00

  • HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024

    Jul 1, 2025, 00:00

  • EE370 The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe

    Jul 1, 2025, 00:00

  • PCR186 JAV-RARAS: Evaluation of Adherence to Clinical Protocol and Therapeutic Guidelines (PCDT) for Mucopolysaccharidosis Type 2 (MPS2) at Codajás Polyclinic - An Analysis of the Value-Based Care Journey

    Jul 1, 2025, 00:00

  • OP5 Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • CO56 Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • EPH61 Algeria's Healthcare System in 2024: Progress Against Persisting Challenges

    Jul 1, 2025, 00:00

  • PCR98 Enhancing Healthcare Quality through Patient-Centered Outcome Measures in Medicare's Merit-based Incentive Payment System

    Jul 1, 2025, 00:00

  • EPH23 Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records

    Jul 1, 2025, 00:00

  • EE479 Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel

    Jul 1, 2025, 00:00

  • P62 Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)

    Jul 1, 2025, 00:00

  • EE511 Descriptive Analysis Of Patients With Psoriasis (PSO) Using Biologics Vs. Non-biologics

    Jul 1, 2025, 00:00

  • HPR43 Unlocking the Potential of OBRSAs in the US: Insights on Challenges, Policy Changes, and Pathways Forward

    Jul 1, 2025, 00:00

  • EE431 Healthcare Costs and Resource Use in Patients With Sjögren's Syndrome (SS): A Systematic Literature Review of Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • EPH9 A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma

    Jul 1, 2025, 00:00

  • EPH171 Gabapentinoid Use, Potential Misuse, and Associated Risk Factors among U.S. Adult Cancer Survivors: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • PCR156 Frequency and Severity of COVID-19 Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Early 2024-2025 Respiratory Season Results of a Nationwide Study

    Jul 1, 2025, 00:00

  • HPR107 Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024

    Jul 1, 2025, 00:00

  • RWD58 Concomitant Usage of Contra-Indicated Medications in Patients With Atrial Fibrillation: A Comparison of Real-World Data Sources in the United States

    Jul 1, 2025, 00:00

  • HPR99 Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • HSD20 An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN

    Jul 1, 2025, 00:00

  • HTA90 Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil

    Jul 1, 2025, 00:00

  • RWD157 K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)

    Jul 1, 2025, 00:00

  • PCR13 Content Validation of the Patient Attainment Scale-Essential Tremor (PAS-ET): A Novel Patient-Reported Outcome Measure Assessing Patient-Level Perceptions of the Importance, Current Function and Definitions of Meaningful Improvement i ...

    Jul 1, 2025, 00:00

  • MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • HPR57 Comparing the Social and Private Value Created by Pembrolizumab 2014-2022

    Jul 1, 2025, 00:00

  • EE481 Budget Impact Analysis of Volanesorsen as a Complement to the Diet in Adult Patients with Familial Chylomicronemia Syndrome (FCS) in Mexico

    Jul 1, 2025, 00:00

  • CO8 Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients

    Jul 1, 2025, 00:00

  • RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments

    Jul 1, 2025, 00:00

  • MT15 RtCGM Use is Associated with Improved Glycemic Control Compared to isCGM in Commercially Insured People with Type 2 Diabetes on Semaglutide and Insulin

    Jul 1, 2025, 00:00

  • PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use

    Jul 1, 2025, 00:00

  • EE215 Pompe Disease in Sweden: A Real-World Evidence Study Investigating Healthcare Resource Utilisation and Costs

    Jul 1, 2025, 00:00

  • MSR82 Effectiveness of Activity Criteria in Stabilizing Patient Cohorts in Open Claims Data for Healthcare Outcomes Research

    Jul 1, 2025, 00:00

  • HPR171 Comparison of Therapeutic Efficacy by Disease for Outpatients Using Herbal Decoctions Based on the Using the Usage and Consumption of Korean Medicine Report in 2020

    Jul 1, 2025, 00:00

  • EPH152 Trends in Cardiovascular and Cancer Mortality Among Texas Residents with Cancer between 2010 and 2019

    Jul 1, 2025, 00:00

  • EE436 Real World Healthcare Resource Utilization (HRU) and Costs Associated With Mantle Cell Lymphoma (MCL) Therapies in the Frontline (1L) and Relapsed/Refractory (R/R) Setting

    Jul 1, 2025, 00:00

  • CO23 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3 (current)
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »